These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Remdesivir and GS-441524 plasma concentrations in patients with end-stage renal disease on haemodialysis. Davis MR; Pham CU; Cies JJ J Antimicrob Chemother; 2021 Feb; 76(3):822-825. PubMed ID: 33152758 [No Abstract] [Full Text] [Related]
30. Prolonged elevation of vancomycin concentrations in a patient with end-stage renal disease. Amodio MI; Monane M; Klein RS South Med J; 1990 Jan; 83(1):77-8. PubMed ID: 2300843 [No Abstract] [Full Text] [Related]
31. [Determination in biologic media of a new beta-blocker, atenolol, by high performance liquid chromatography]. Decourt S; Flouvat B J Chromatogr; 1979 Jun; 174(1):258-63. PubMed ID: 546890 [No Abstract] [Full Text] [Related]
32. Clearance of middle molecules during haemodialysis and haemodiafiltration: new insights. Leypoldt JK; Holmes CJ; Rutherford P Nephrol Dial Transplant; 2012 Dec; 27(12):4245-7. PubMed ID: 23235952 [No Abstract] [Full Text] [Related]
33. The final word. La Greca G; Klinkmann H; Valderrábano F; Zucchelli P Kidney Int Suppl; 2000 Aug; 76():S156-9. PubMed ID: 10936813 [No Abstract] [Full Text] [Related]
34. The analysis of atenolol in plasma using an automated sample preparation technique. Dale AD; Turner SE J Pharm Biomed Anal; 1990; 8(8-12):1055-8. PubMed ID: 2100586 [No Abstract] [Full Text] [Related]
35. Management of end-stage kidney disease: medical aspects. Briggs WA Mil Med; 1975 Sep; 140(9):606-8. PubMed ID: 808764 [No Abstract] [Full Text] [Related]
36. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. Bouchard J; Shepherd G; Hoffman RS; Gosselin S; Roberts DM; Li Y; Nolin TD; Lavergne V; Ghannoum M; Crit Care; 2021 Jun; 25(1):201. PubMed ID: 34112223 [TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacokinetics of atenolol--a review. Kirch W; Görg KG Eur J Drug Metab Pharmacokinet; 1982; 7(2):81-91. PubMed ID: 6749509 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of ketoprofen in treating primary dysmenorrhea. Gleeson S; Sorbie J Can Med Assoc J; 1983 Oct; 129(8):842-4. PubMed ID: 6351994 [TBL] [Abstract][Full Text] [Related]
39. Plasma levels of atenolol after haemodialysis in patients with end stage renal disease. Rosseel MT; Bogaert MG; Christiaens M; Verpooten GA; De Broe ME Arch Int Pharmacodyn Ther; 1979 May; 239(1):176. PubMed ID: 485716 [No Abstract] [Full Text] [Related]
40. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. Flouvat B; Decourt S; Aubert P; Potaux L; Domart M; Goupil A; Baglin A Br J Clin Pharmacol; 1980 Apr; 9(4):379-85. PubMed ID: 7378254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]